FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to laboratory diagnostics, and can be used to determine an anticoagulant potential of a vascular wall. That is ensured by double blood viscosity assessment by low-frequency piezocutaneous elastography (LPTEG) before and after dissolving an aliquot of whole blood 0.9 % with normal saline. Parameters of the LPTEG curve are determined: A11 – index of the minimum level of whole blood plasma LPTEG amplitude, where t11 is its reaching time; t31 is the time of achieving a gelation point in whole blood – the beginning of the fibrin polymerisation stage; A12 is an index of a minimum level of the curve of the LPTEG after adding an aliquot of whole blood to physiological solution, where t12 is its reaching time; t32 is the time of reaching the blood jellying point – the beginning of the fibrin polymerisation stage. If values A12 lower than A11, and if value t12, t32 greater than t11, t31 anticoagulant potential of the vascular wall is defined as normal. If values A12 higher than A11, and if value t12, t32 less than t11, t31, anticoagulant potential of the vascular wall is defined as reduced.
EFFECT: invention enables determining the anticoagulant potential of a vascular wall in a patient.
1 cl, 4 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ESTIMATION OF INCREASED RISK OF PHLEBOTHROMBOSES FORMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2016 |
|
RU2624859C1 |
METHOD OF ESTIMATION OF AGGREGATION ACTIVITY OF THROMBOCYTES | 2016 |
|
RU2666945C2 |
METHOD FOR CORRECTING HYPERCOAGULABLE STATE WHEN ANTITUMOR DRUG CISPLATIN IS ADMINISTERED BY INJECTION | 2020 |
|
RU2743848C1 |
METHOD FOR PREDICTION OF INTRAOPERATIVE BLOOD LOSS IN PATIENTS WITH IDIOPATHIC SCOLIOSIS | 2016 |
|
RU2635503C1 |
METHOD FOR TESTING ANTICOAGULANT ACTIVITY OF BLOOD | 2012 |
|
RU2530584C2 |
METHOD OF BLOOD SAMPLING IN SMALL LABORATORY ANIMALS FOR PERFORMANCE OF LOW-FREQUENCY PIEZOTROMBOELASTOGRAPHY | 2017 |
|
RU2648032C1 |
METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
METHOD FOR PERFORMING LOW-FREQUENCY PIEZOTHROMBOELASTOGRAPHY IN SMALL LABORATORY ANIMALS | 2016 |
|
RU2634567C1 |
METHOD FOR DETERMINING ASPIRIN RESISTANCE | 2019 |
|
RU2700000C1 |
METHOD FOR ASSESSING LEVEL OF UNFRACTIONATED HEPARIN INDUCED ANTICOAGULATION IN HAEMODIALYSIS IN PATIENTS WITH ACUTE RENAL INJURY | 2014 |
|
RU2571505C1 |
Authors
Dates
2019-06-06—Published
2018-06-06—Filed